The Centers for Disease Control
|
|
- Brendan Perkins
- 7 years ago
- Views:
Transcription
1 Prevention and Treatment of Sexually Transmitted Diseases: An Update Michele Van Vranken, MD, Teen Age Medical Service, Children s Hospitals and Clinics of Minnesota, Minneapolis, Minnesota The Centers f Disease Control and Prevention recently published revised guidelines f the prevention and treatment of sexually transmitted diseases. One new treatment strategy is the use of azithromycin as a primary, rather than alternative, medication f pregnant women with Chlamydia trachomatis infection. Quinolone-resistant Neisseria gonrhoeae infection continues to increase in the United States; therefe, quinolones are no longer recommended f treatment of this infection. Expedited partner therapy gives physicians another option when addressing the need to treat partners of persons diagnosed with N. gonrhoeae C. trachomatis infection. Tinidazole is now available in the United States and can be used to manage trichomoniasis, including trichomoniasis resistant to metronidazole. Shter courses of antiviral medication can be used f episodic therapy of recurrent genital herpes. Because of increasing resistance, close follow-up is required if azithromycin is used as an alternative treatment in the management of primary secondary syphilis. Unexpected increases in the rates of lymphogranuloma venereum have occurred in the Netherlands, and physicians should remain vigilant f symptoms of this disease in the United States. (Am Fam Physician 2007;76: , Copyright 2007 American Academy of Family Physicians.) Patient infmation: A handout on sexually transmitted diseases, written by the auth of this article, is provided on page The Centers f Disease Control and Prevention (CDC) recently released updated guidelines f the prevention and treatment of sexually transmitted diseases (STDs). 1 These guidelines were developed through a systematic review of evidence that has become available since the 2002 guidelines were issued, as well as through expert consultation. Health Education Education and counseling are the main strategies in the prevention and control of STDs. Evaluation includes addressing key areas of sexual health referred to as the Five P s: Partners, Prevention of pregnancy, Protection from STDs, Practices, and Past histy of STDs. Addressing this infmation with patients creates an opptunity f physicians to provide counseling and education while taking into account each patient s individual risk facts and goals. The use of motivational interviewing focuses on the specific behavis of the patient and places a greater emphasis on moving toward individually defined, achievable, risk-reduction goals. Table 1 1 lists symptoms and diagnoses of selected STDs. A visit with a physician f the screening, diagnosis, treatment of STDs also provides an opptunity f the physician to educate the patient about human immunodeficiency virus (HIV). Patients may not be aware that the presence of an STD may facilitate the transmission of HIV if they are exposed to the virus. Because some patients who are HIV positive are unaware of their diagnosis, the CDC now encourages HIV screening f patients in all health care settings. Although patients may choose not to be tested, written consent f testing is no longer recommended (unless mandated by the state). 2 Chlamydia Trachomatis Chlamydia trachomatis is the most common reptable infectious disease in the United States, with almost 1 million cases repted in Few recommendations have changed f the treatment of persons infected with C. trachomatis; however, azithromycin (Zithromax) is now recommended as a primary, rather than alternative, Downloaded from the American Family Physician Web site at Copyright 2007 American Academy of Family Physicians. F the private, noncommercial use of one individual user of the Web site. All other rights reserved. Contact copyrights@aafp.g f copyright questions and/ permission requests.
2 SORT: KEY RECOMMENDATIONS FOR PRACTICE Clinical recommendation Azithromycin (Zithromax) is recommended as a first-line treatment f Chlamydia trachomatis infection during pregnancy. Quinolones should not be used in the treatment of Neisseria gonrhoeae infection. Provision of expedited partner treatment lessens the risk of reinfection f patients treated f N. gonrhoeae C. trachomatis infection. Tinidazole (Tindamax) is an appropriate treatment option f metronidazole (Flagyl)-resistant trichomoniasis. Evidence rating References Comments A 4-6 Based on randomized controlled trials C 9 Based on expert opinion B Based on limited randomized controlled trial evidence B 14, Based on limited studies A = consistent, good-quality patient-iented evidence; B = inconsistent limited-quality patient-iented evidence; C = consensus, diseaseiented evidence, usual practice, expert opinion, case series. F infmation about the SORT evidence rating system, see page treatment in pregnant women (Table 2). 1 This change occurred because of recent evidence suppting azithromycin as safe and effective during pregnancy. 4-6 Neisseria Gonrhoeae Since the publication of the 2002 STD treatment guidelines, the rate of quinoloneresistant Neisseria gonrhoeae has continued to increase throughout the United States. As resistance increases, recommendations continue to change. Previous recommendations focused on the high levels of resistance in areas of Asia and the Pacific, Califnia, Hawaii, and in some specific populations in the United States (e.g., men who have sex with men). In 2004, 6.8 percent of isolates collected by the CDC s Gonococcal Isolate Surveillance Project were resistant to ciprofloxacin (Cipro); when samples from Califnia and Hawaii were excluded, 3.6 percent of isolates were resistant. 7 Quinolone-resistant N. gonrhoeae is me common in men who have sex with men than in men who have sex exclusively with women (23.8 versus 2.9 percent, respectively) 7 ; however, the rate of quinoloneresistant N. gonrhoeae continues to increase among heterosexual persons. In heterosexual men, the prevalence rose Table 1. Symptoms and Diagnoses of Sexually Transmitted Diseases Disease Symptoms Labaty diagnosis Chlamydia Gonrhea Trichomoniasis Genital herpes simplex virus Syphilis Lymphogranuloma venereum Asymptomatic, dysuria, discharge (penile vaginal), pain with sex, abdominal testicular pain, breakthrough bleeding Asymptomatic, dysuria, discharge (penile vaginal), pain with sex, abdominal testicular pain, breakthrough bleeding Asymptomatic, vaginal discharge with od itching Asymptomatic, recurrent, painful vesicular ulcerative lesions in the genital area Asymptomatic, painless ulcer (chancre), systemic rash including palms and soles, cardiovascular and neurologic involvement Inguinal adenopathy, self-limited papule ulcer, proctocolitis Nucleic acid amplification test of urine, endocervical sample, urethral sample Nucleic acid amplification test of urine, endocervical sample, urethral sample; gonococcal culture f rectal pharyngeal specimens Saline wet mount; rapid antigen testing; Trichomonas culture Viral culture; type-specific serologic test Serologic tests (nontreponemal and treponemal); darkfield examination Procedures not readily available to differentiate lymphogranuloma venereum from nonlymphogranuloma venereum Chlamydia trachomatis Infmation from reference American Family Physician Volume 76, Number 12 December 15, 2007
3 Table 2. Treatment of Chlamydia trachomatis Infection STD Update Nonpregnant women Recommended Azithromycin (Zithromax) 1 g ally once Doxycycline (Vibramycin) 100 mg ally twice daily f seven days Alternative Erythromycin base 500 mg ally four times daily f seven days Erythromycin ethylsuccinate 800 mg ally four times daily f seven days Ofloxacin (Floxin)* 300 mg ally twice daily f seven days Levofloxacin (Levaquin) 500 mg ally daily f seven days Pregnant women Recommended Azithromycin 1 g ally once Amoxicillin 500 mg three times daily f seven days Alternative Erythromycin base 500 mg four times daily f seven days 250 mg four times daily f 14 days Erythromycin ethylsuccinate 800 mg four times daily f seven days 400 mg four times daily f 14 days * Brand no longer available in the United States. Lower-dose erythromycin regimens may be considered if there is gastrointestinal intolerance to higher dosages. Infmation from reference 1. from 0.9 percent in 2002 to 3.8 percent in 2005, 8 and preliminary data from the first six months of 2006 indicate an increase to 6.7 percent. 9 Current guidelines reflect these changes (Table 3 1 ) by no longer recommending quinolones as treatment f N. gonrhoeae infection. 9 Expedited Partner Treatment It is standard practice to recommend that sex partners of patients diagnosed with an STD be treated to decrease the risk of reinfection and to decrease the incidence and prevalence of STDs among social netwks. The primary goal is f the patient s sex partners to be seen by a physician f testing, treatment, and education. However, there may be clinical situations in which this cannot be accomplished (e.g., because of patient, partner, resource limitations). In these circumstances, the CDC recommends that physicians consider using expedited partner treatment. Expedited partner treatment is the practice of treating sex partners of persons diagnosed with an STD without medical evaluation prevention counseling; this is usually done by providing the patient with appropriate treatment to give to his her partner. Three randomized controlled trials sponsed by the CDC evaluated the behavial and clinical outcomes of expedited partner treatment compared with traditional treatment programs through patient physician referral. In summary, the evidence suppts expedited partner treatment as an option in patients with N. gonrhoeae C. trachomatis infection ; however, it is imptant f physicians to be aware of their state s legal provision f this practice. Table 3. Treatment of Uncomplicated Neisseria gonrhoeae Infection Cervical, urethral, rectal infection Recommended Ceftriaxone (Rocephin) 125 mg IM once Alternative Pharyngeal infection Cefixime (Suprax) Single-dose cephalospin regimens* 400 mg ally once Recommended Ceftriaxone 125 mg IM once NOTE: Quinolones should not be used to treat Neisseria gonrhoeae infection. All therapies should also include the treatment of Chlamydia trachomatis infection if it has not been ruled out. IM = intramuscularly. * See iginal guidelines f specific dosages. Infmation from reference 1. December 15, 2007 Volume 76, Number 12 American Family Physician 1829
4 Table 4. Treatment of Trichomoniasis Recommended Metronidazole (Flagyl)* 2 g ally once Tinidazole (Tindamax)* 2 g ally once Alternative Metronidazole* 500 mg ally twice daily f seven days * Patients should be advised to avoid consuming alcohol during treatment with metronidazole tinidazole. Abstinence from alcohol should continue f 24 hours after completion of metronidazole 72 hours after completion of tinidazole. Tinidazole is U.S. Food and Drug Administration pregnancy categy C; its safety during pregnancy has not been well evaluated. Infmation from reference 1. Table 5. Treatment of Genital Herpes Simplex Virus Type Agent Dosage First clinical episode Episodic therapy f recurrent genital herpes Suppressive therapy f recurrent genital herpes Acyclovir (Zovirax) Famciclovir (Famvir) Valacyclovir (Valtrex) Acyclovir Famciclovir Valacyclovir Acyclovir Famciclovir Valacyclovir 400 mg ally three times daily f seven to 10 days 200 mg ally five times daily f seven to 10 days 250 mg ally three times daily f seven to 10 days 1 g ally twice daily f seven to 10 days 400 mg ally three times daily f five days 800 mg ally twice daily f five days 800 mg ally three times daily f two days 125 mg ally twice daily f five days 1 g ally twice daily f one day 500 mg ally twice daily f three days 1 g ally once daily f five days 400 mg ally twice daily 250 mg ally twice daily 500 mg ally once daily* 1 g ally once daily * This dosage may be less effective than other valacyclovir acyclovir dosing regimens in patients with frequent recurrences (me than 10 per year). Infmation from reference 1. Trichomoniasis Since publication of the 2002 STD treatment guidelines, options f the diagnosis and treatment of trichomoniasis have continued to improve. Tinidazole (Tindamax), a nitroimidazole that is similar to metronidazole (Flagyl), has been approved by the U.S. Food and Drug Administration (FDA) f the treatment of trichomoniasis. A review of randomized controlled trials suggests that tinidazole is equivalent superi to metronidazole, with the recommended metronidazole regimen resulting in cure rates of 90 to 95 percent and the recommended tinidazole regimen resulting in cure rates of 86 to 100 percent (Table 4 1 ). 1,13 Additionally, it is estimated that approximately 2.5 to 5 percent of Trichomonas vaginalis isolates now show some level of resistance to metronidazole. 1,14 Tinidazole has a higher serum half-life and better penetration into the genitourinary tissues, 15,16 which suggests that it is a potential treatment f metronidazoleresistant trichomoniasis. 14,17,18 Diagnostic options f trichomoniasis have also expanded. Although the most common diagnostic method f trichomoniasis involves microscopy of vaginal secretions, the sensitivity of this method is only 60 to 70 percent. Additional FDA-approved, pointof-care tests include the Osom Trichomonas Rapid Test, which uses immunochromatographic capillary flow dipstick technology, and the BD Affirm VPIII Microbial Identification Test, which is a nucleic acid probe test. Both have a sensitivity of me than 83 percent and specificity of me than 97 percent; however, false-positive results are a concern in areas of low disease prevalence. 1 Genital Herpes Simplex Virus Most persons infected with genital herpes simplex virus (HSV) do not show clinical signs of disease. However, antiviral treatments f persons with clinical symptoms provide some symptomatic relief, as well as a lower viral burden and potential f transmission. Additional alternatives f episodic treatment of recurrent genital HSV require a shter duration of treatment (one two days of treatment versus five days of 1830 American Family Physician Volume 76, Number 12 December 15, 2007
5 treatment) (Table 5 1 ). Suppressive therapy can reduce genital HSV recurrences by 70 to 80 percent in patients with at least six recurrences per year 1 ; however, in the revised guidelines, there is greater emphasis on the use of suppressive therapy to reduce disease transmission. One study of daily treatment with 500 mg of valacyclovir (Valtrex) decreased the rate of viral transmission in heterosexual partners. 19 Patients with HSV are encouraged to consider suppressive treatment as part of the overall strategy in reducing transmission, regardless of the number of recurrences per year. Syphilis Rates of primary and secondary syphilis increased f the fifth consecutive year in 2005 (8,176 cases repted) to their highest levels since Penicillin G benzathine continues to be the primary antibiotic treatment recommended (Table 6 1 ). The CDC guidelines also include a discussion of treatment with doxycycline (Vibramycin), tetracycline, and ceftriaxone (Rocephin) in patients who are allergic to penicillin. The use of azithromycin is also discussed. Although earlier studies suggested that azithromycin given as a single 2-g dose might be effective, 20,21 several cases of treatment failure, as well as repted cases of isolate resistance have been noted, suggesting that close follow-up is needed if azithromycin is used. 22 Lymphogranuloma Venereum Lymphogranuloma venereum (LGV) is caused by C. trachomatis serovars L1, L2, L3. Although still relatively uncommon in the United States and in western European countries, a significant increase in cases was noted in the Netherlands in 2004 among men who have sex with men. 23 The CDC addresses this concern by adding infmation to the guidelines about the clinical presentation of LGV. Presentation can include a nontender papule that may ulcerate after three to 30 days at the site of inoculation, and signs of proctocolitis (e.g., mucoid hemrhagic discharge, anal pain, constipation, fever tenesmus) in persons with a histy of rectal exposure to the bacteria. These symptoms in Table 6. Treatment of Syphilis Type Agent Dosage Primary, secondary, and early latent Late latent, latent of unknown duration, and tertiary IM = intramuscularly. Infmation from reference 1. at-risk patients should prompt further diagnostic and treatment consideration. Diagnosis is primarily clinical because culture and nucleic acid amplification testing are not specific f LGV caused by C. trachomatis. If a patient has symptoms and specific typing is desired, contact with state local health departments is often required. The CDC continues to recommend a three-week course of doxycycline when symptoms testing suggest LGV, although erythromycin is an alternative (Table 7 1 ). The Auth Penicillin G benzathine Penicillin G benzathine MICHELE VAN VRANKEN, MD, is a family physician at Teen Age Medical Service, Children s Hospital and Clinics of Minnesota in Minneapolis. She also is the medical direct of the Annex Teen Clinic in Robbinsdale, Minn., and the West Suburban Teen Clinic in Excelsi, Minn. Dr. Van Vranken received her medical degree from Rush Medical College in Chicago, Ill., and completed a family medicine residency and community and adolescent fellowship at the Ramsey Family and Community Medicine Residency Program, Minneapolis. She also has a certificate of added qualification in adolescent medicine. 2.4 million units IM once 2.4 million units IM weekly f three weeks Table 7. Treatment of Lymphogranuloma Venereum Recommended Doxycycline (Vibramycin) 100 mg ally twice daily f 21 days Alternative* Erythromycin base 500 mg ally four times daily f 21 days * Some specialists believe that azithromycin (Zithromax) 1 g ally weekly f three weeks is an effective treatment option, but data are lacking. Infmation from reference 1. December 15, 2007 Volume 76, Number 12 American Family Physician 1831
6 Address crespondence to Michele Van Vranken, MD, Teen Age Medical Service, Children s Hospitals and Clinics of Minnesota, 2425 Chicago Ave. S., Minneapolis, MN ( michele.vanvranken@childrensmn.g). Reprints are not available from the auth. Auth disclosure: Nothing to disclose. REFERENCES 1. Wkowski KA, Berman SM; Centers f Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006 [Published crection appears in MMWR Recomm Rep. 2006;55(36):997]. MMWR Recomm Rep. 2006;55(RR-11): Branson BM, Handsfield HH, Lampe MA, et al.; Centers f Disease and Control and Prevention. Revised recommendations f HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14): Jajosky RA, Hall PA, Adams DA, et al.; Centers f Disease Control and Prevention. Summary of notifiable diseases United States, MMWR Mb Mtal Wkly Rep. 2006;53(53): Jacobson GF, Autry AM, Kirby RS, Liverman EM, Motley RU. A randomized controlled trial comparing amoxicillin and azithromycin f the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol. 2001;184(7): Kacmar J, Cheh E, Montagno A, Peipert JF. A randomized trial of azithromycin versus amoxicillin f the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol. 2001;9(4): Rahangdale L, Guerry S, Bauer HM, et al. An observational coht study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis. 2006;33(2): U.S. Dept. of Health and Human Services. Sexually transmitted disease surveillance 2004 supplement. Gonococcal Isolate Surveillance Project (GISP) annual rept Atlanta, Ga.: Centers f Disease Control and Prevention, National Center f HIV, STD, and TB Prevention, Division of STD Prevention, Accessed July 17, U.S. Dept. of Health and Human Services. Sexually transmitted disease surveillance 2005 supplement. Gonococcal Isolate Surveillance Project (GISP) annual rept Atlanta, Ga.: Centers f Disease Control and Prevention, National Center f HIV, STD, and TB Prevention, Division of STD Prevention, pdf. Accessed July 17, Centers f Disease and Control and Prevention. Update to CDC s sexually transmitted diseases treatment guidelines, 2006: fluoquinolones no longer recommended f treatment of gonococcal Infections. MMWR Mb Mtal Wkly Rep. 2007;56(14): Schillinger JA, Kissinger P, Calvet H, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis. 2003;30(1): Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent persistent gonrhoeae chlamydial infection. N Engl J Med. 2005;352(7): Kissinger P, Mohammed H, Richardson-Alston G, et al. Patient-delivered partner treatment f male urethritis: a randomized, controlled trial. Clin Infect Dis. 2005;41(5): Fna F, Gülmezoglu AM. Interventions f treating trichomoniasis in women. Cochrane Database Syst Rev. 2003;(2):CD Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy f metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis. 2001;33(8): Schmid G, Narcisi E, Mosure D, Sec WE, Higgins J, Meno H. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med. 2001;46(5): Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery GS. Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy. Drugs. 1976;11(6): Hager WD. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case repts of three patients. Sex Transm Dis. 2004;31(6): Hamed KA, Studemeister AE. Successful response of metronidazole-resistant trichomonal vaginitis to tinidazole. A case rept. Sex Transm Dis. 1992;19(16): Cey L, Wald A, Patel R, et al.; Valacyclovir HSV Transmission Study Group. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350(1): Hook EW, Martin DH, Stephens J, Smith BS, Smith K. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G f treatment of early syphilis. Sex Transm Dis. 2002;29(8): Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine f the treatment of early syphilis. N Engl J Med. 2005;353(12): Lukehart SA, Godnes C, Molini BJ, et al. Macrolide resistance in Treponema palladium in the United States and Ireland. N Engl J Med. 2004;351(2): Centers f Disease Control and Prevention. Lymphogranuloma venereum among men who have sex with men Netherlands, MMWR Mb Mtal Wkly Rep. 2004;53(42): American Family Physician Volume 76, Number 12 December 15, 2007
Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon
Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon Oregon Health Authority Center for Public Health Practice HIV/STD/TB Section Principles of
More informationCDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H.
CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. Clinical Faculty, CA Prevention Training Center Disclosure Information Sharon Adler MD, MPH I have no financial relationships
More informationTHIS IS AN OFFICIAL NH DHHS HEALTH ALERT
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@nh.gov August 13, 2015 1400 EDT (2:00 PM EDT) NH-HAN 20150813 Updated Centers for Disease Control (CDC)
More informationCalifornia Guidelines for STD Screening and Treatment in Pregnancy
California Guidelines for STD Screening and Treatment in Pregnancy These guidelines were developed by the California Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch
More informationChanges in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011
Changes in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011 Gale Burstein, MD, MPH, FAAP, FSAHM 1 Amanda Jacobs, MD, FAAP, 2 Dmitry Kissin, MD, MPH, 3
More informationCalifornia Gonorrhea Treatment Guidelines
Califnia Gonrhea Treatment Guidelines These guidelines were developed by the Califnia Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch in conjunction with the Califnia
More information2014 CDC Treatment Guidelines for STDs What s New, What s Important, What s Essential. STD Treatment Guidelines. How are the guidelines prepared?
2014 CDC Treatment Guidelines for STDs What s New, What s Important, What s Essential Bradley Stoner, MD, PhD Associate Professor, Washington University School of Medicine Medical Director, St. Louis STD/HIV
More informationSTD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative treatment
STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative Pregnancy Chlamydia Chancroid Epdidymitis Gonorrhea: Uncomplicated (cx, urethra, and rectum):
More informationTreatment of sexually transmitted and other genital infections
www.bpac.org.nz keyword: sti Treatment of sexually transmitted and other genital infections Key reviewer: Dr Murray Reid, Sexual Health Physician, Auckland Sexual Health Service General points: If one
More informationGLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS
GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS IN Dr.P.Bhalla Director Professor and Head Dept. of Microbiology Maulana Azad Medical College New Delhi, INDIA STDs & RTIs l HIV l Gonococcal infections/
More informationSTANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT
STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT RELEASE DATE: REVIEW INTERVAL: YEARLY REVIEW DATE: SITE/SERVICE UNIT: IMPLEMENTATION DATE: REVIEWED BY: CONTACT: APPROVED BY: CONTENTS
More informationRhode Island Department of Health Division of Infectious Diseases and Epidemiology
Rhode Island Department of Health Division of Infectious Diseases and Epidemiology STD (Sexually Transmitted Disease) PROGRAM Expedited Partner Therapy (EPT) for STDs Guidance for Medical Providers in
More informationThe Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011
The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011 Section 5: Screening, Treating and Reporting Chlamydia While the information
More informationTREATMENT OF STI CONTACTS
This decision support tool is effective as of October 2014. For more information or to provide feedback on this or any other decision support tool, email certifiedpractice@crnbc.ca TREATMENT OF STI CONTACTS
More informationFrequently Asked Questions
Frequently Asked Questions Testing for Gonorrhea Q1: What test should be completed for accurately diagnosing gonorrhea? A1: Testing is done with either a culture or a NAAT (nucleic acid amplification test).
More informationSYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization
WHO COLLABORATING CENTRE FOR RESEARCH IN HUMAN REPRODUCTION Hôpitaux Universitaires de Genève SYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization Dr SALONEY NAZEER Department of Gynaecology
More informationsigns suggesting chlamydia:
Chlamydia - uncomplicated genital - Management View full scenario When should I suspect and test for chlamydia? Women: o Test for chlamydia if they are sexually active with symptoms and signs suggesting
More informationSexually Transmitted Infections (STI) One Day Update
Sexually Transmitted Infections (STI) One Day Update February 2015 Overview STI Guideline Changes National STI Services Results Reporting High Transmission Areas: Key Populations STI Guideline Changes
More informationYukon Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2015
Yukon Treatment Guidelines f Sexually Transmitted Infections (STI) in Adolescents and Adults 2015 The Yukon Treatment Guidelines f Sexually Transmitted Infections (STI) in Adolescents and Adults 2015 has
More information12/3/2015. M genitalium and urethritis and cervicitis. Consider M gent Rx in persistent /recurrent urethritis and in persistent cervicitis and PID
M genitalium and urethritis and cervicitis Consider M gent Rx in persistent /recurrent urethritis and in persistent cervicitis and PID Azithromycin 1 gm more effective odoxy ineffective oaz Resistance
More informationDeveloped by: California Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch. In collaboration with:
Best Practices for the Prevention and Early Detection of Repeat Chlamydial and Gonococcal Infections: Effective Partner Treatment and Patient Retesting Strategies for Implementation in California Health
More informationTitle: Antibiotic Guideline for Acute Pelvic Inflammatory Disease
Title: Antibiotic Guideline for Acute Pelvic Inflammatory Disease Version 3 Date ratified December 2007 Review date December 2009 Ratified by NUH Antimicrobial Guidelines Committee Gynaecology Directorate
More informationTHE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE
THE UNITED REPUBLIC OF TANZANIA Treat for Lymphogranuloma venereum MINISTRY OF HEALTH AND SOCIAL WELFARE Appoint to return after Patient complains of Use Discharge from Continue to 2nd Refer to surgeon
More informationSTI case management. Francis Ndowa - GFMER Theodora Wi - WHO
Training Course in Sexual and Reproductive Health Research 2014 Module: Principles and Practice of Sexually Transmitted Infections Prevention and Care STI case management Francis Ndowa - GFMER Theodora
More informationFrequently Asked Questions
Guidelines for Testing and Treatment of Gonorrhea in Ontario, 2013 Frequently Asked Questions Table of Contents Background... 1 Treatment Recommendations... 2 Treatment of Contacts... 4 Administration
More information2010 STD Treatment Guidelines: Update for Primary Care Providers
2010 STD Treatment Guidelines: Update for Primary Care Providers Sharon Adler, MD MPH STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Overview CDC
More informationExpedited Partner Therapy for Chlamydia Trachomatis and Neisseria Gonorrhoeae: Guidance for Health Care Professionals in Indiana
Indiana State Department of Health Introduction Expedited Partner Therapy for Chlamydia Trachomatis and Neisseria Gonorrhoeae: Guidance for Health Care Professionals in Indiana Indiana State Department
More informationGONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1)
Key practice notes: 1 st line therapy GONORRHOEA Decreasing sensitivity of gonorrhoea to cephalosporins is now a real threat: CEFTRIAXONE 500mg IM stat first-line for all gonococcal infections AZITHROMYCIN
More information9/28/2015. Sexually Transmitted Infections. STDs in Minnesota: Number of Cases Reported in 2013*
Sexually Transmitted Infections SANE-A TRAINING 2015 Barbara Kern-Pieh RN MS CNM SANE-A SANE-P STDs in Minnesota: Number of Cases Reported in 2013* Total of 23,133 STD cases reported to MDH in 2013: 18,724
More informationAIR FORCE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS
AIR FORCE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS An Air Force addendum to the TRI-SERVICE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS Prepared by: Air Force Institute for Operational Health
More informationSomething for Everyone!
Common Sexually Transmitted Diseases: STD 101 for Clinicians Something for Everyone! Prepared by John F. Toney, M.D., Associate Professor of Medicine, Univ. of South Florida College of Medicine and Laura
More informationThe incidence of chlamydial infection
Diagnosis and Treatment of Chlamydia trachomatis Infection KARL E. MILLER, M.D., University of Tennessee College of Medicine, Chattanooga, Tennessee Chlamydia trachomatis infection most commonly affects
More informationSuppressive Therapy for Genital Herpes
CLINICAL GUIDELINE Suppressive Therapy for Genital Herpes Compiled by Robin Tideman (edited by Adrian Mindel) 1AUSTRALIAN HERPES MANAGEMENT FORUM Introduction Most genital herpes is caused by the herpes
More informationLeader's Resource. Note: Both men and women can have an STD without physical symptoms.
Leader's Resource Information on Sexually Transmitted Diseases (STDs) Signs and Symptoms of STDs Note: Both men and women can have an STD without physical symptoms. Any of the following can indicate to
More informationChlamydia Challenge. CONTENTS 2010 CDC STD Treatment Guidelines SPRING 11. Texas Oklahoma Louisiana Arkansas New Mexico
Chlamydia Challenge SPRING 11 Region VI Infertility Prevention Advisory Committee (RIPAC) Arkansas, Louisiana, New Mexico, Oklahoma and Texas CONTENTS 2010 CDC STD Treatment Guidelines REGIONAL UPDATES:
More informationTreatment of Chlamydial Cervicitis During Pregnancy
Infectious Diseases in Obstetrics and Gynecology 3:189-192 (1995) (C) 1996 Wiley-Liss, Inc. Efficacy and Tolerance of Single-Dose Azithromycin for Treatment of Chlamydial Cervicitis During Pregnancy Joseph
More informationChlamydia trachomatis genital infection is the
CME Activity Inside and Online CHLAMYDIA TESTING AND TREATMENT Take a sexual history of all patients, including adolescents anyone who is sexually active is at risk for chlamydia infection. Screen sexually
More informationAlberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2012
Alberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2012 General for STI Given the current rates of STI in Alberta, Some STI are under the Patients and contacts
More informationYes, I know I have genital herpes:
Counseling Messages for Herpes Simplex Type II (HSV-II) Genital herpes Always take the time to attend to the participant s feelings and emotional state; for some people, this is the most devastating news
More informationSexual Health and Sexually Transmitted Infections Prevention and Control Protocol, 2013 (Revised)
Sexual Health and Sexually Transmitted Infections Prevention and Control Protocol, 2013 (Revised) Preamble The Ontario Public Health Standards (OPHS) are published by the Minister of Health and Long- Term
More informationInfections during pregnancy affect the
Screening and Treatment for Sexually Transmitted Infections in Pregnancy BARBARA A. MAJERONI, MD, and SREELATHA UKKADAM, MBBS State University of New York at Buffalo, Buffalo, New York Many sexually transmitted
More informationSexual STIs - A Guide to Managing Them
Drug review STIs Optimal management of common STIs in general practice Nadi Gupta MRCP and George Kinghorn MD, FRCP Skyline Imaging Ltd STIs can be detrimental to both physical and psychological health
More informationHIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline
HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline Background... 2 Screening... 2 Recommendations... 2 Ordering and consent... 2 Indications for Periodic HIV Screening...
More informationCoding guide for routine HIV testing in health care settings
Coding guide f routine HIV testing in health care settings Background In September of 2006, CDC issued recommendations f Human immunodeficiency virus (HIV) testing in health care settings. The Revised
More informationInfection caused by the transmission of Trichomonas vaginalis (T. vaginalis) during sexual contact in which body fluids are exchanged.
This decision support tool is effective as of November 2015. For more information or to provide feedback on this or any other decision support tool, email certifiedpractice@crnbc.ca TRICHOMONIASIS DEFINITION
More informationSlide 1: Chlamydia and Gonorrhea: What You and Your Clients Need to Know. Welcome to Chlamydia and Gonorrhea: What You and Your Clients Need to Know.
Slide 1: Chlamydia and Gonorrhea: What You and Your Clients Need to Know Welcome to Chlamydia and Gonorrhea: What You and Your Clients Need to Know. This is a presentation for healthcare providers about
More informationClinical Aspects of Diagnosis of Gonorrhea and Chlamydia Infection in an Acute Care Setting
BRIEF REPORT Clinical Aspects of Diagnosis of Gonorrhea and Chlamydia Infection in an Acute Care Setting Supriya D. Mehta, 1 Richard E. Rothman, 2 Gabor D. Kelen, 2 Thomas C. Quinn, 3,4 and Jonathan M.
More informationLearning Objectives. Sexual Transmission. Partners. The Hidden Epidemic Published in: 1997. STD Medical Update
STD Medical Update Learning Objectives Patricia R Jennings DrPH, PA C Professor, University of Alabama at Birmingham Alabama / North Carolina Sexually Transmitted Disease Prevention and Training Center
More informationPatient-Delivered Partner Therapy for Chlamydia trachomatis and Neisseria gonorrhoeae: Guidance for Medical Providers in California
Patient-Delivered Partner Therapy for Chlamydia trachomatis and Neisseria gonorrhoeae: Guidance for Medical Providers in California These guidelines were developed by: California Department of Public Health
More informationENHANCING ADOLESCENT SEXUAL HEALTH
ENHANCING ADOLESCENT SEXUAL HEALTH SERVICES BY CREATING AN ADOLESCENT MEDICAL HOME Gale R. Burstein, MD, MPH, FAAP, FSAHM Commissioner, Erie County Department of Health, Associate Clinical Professor, SUNY
More informationVirtual Mentor American Medical Association Journal of Ethics November 2008, Volume 10, Number 11: 708-718.
Virtual Mentor American Medical Association Journal of Ethics November 2008, Volume 10, Number 11: 708-718. CINICAL CASE Ethics of Expedited Partner Therapy Commentary by Matthew R. Golden, MD, MPH, and
More informationSpecimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing
Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing Overview Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are two of the most common sexually
More informationSexually Transmitted Infections. Sexually Transmitted Pathogens. A few general points... Urethritis MID 15. Clinical Scenario #1. Christine Hogan M.D.
Sexually Transmitted Infections Christine Hogan M.D. Source: Florida STD/HIV Prevention Training Center 34 Sexually Transmitted Pathogens Bacteria Neisseria gonorrhoeae Chlamydia trachomatis Mycoplasma
More informationPartner Services Providers. Quick Guide
Partner Services Providers Quick Guide This pamphlet is meant for use by Disease Intervention Specialists and others conducting partner services activities. High Priority Index Patients for Partner Services
More informationA guide for people with genital herpes
A guide for people with genital herpes Contents Getting the facts 4 The key facts 6 What is genital herpes? 8 Genital herpes symptoms 10 Getting tested 12 The first outbreak 14 Recurrent outbreaks 16 Common
More informationChlamydia THE FACTS. How do people get Chlamydia?
What is Chlamydia? Chlamydia is a common bacterial infection that is sexually transmitted and often causes no symptoms. If not treated, chlamydia can damage reproductive organs and make it difficult for
More informationDiseases that can be spread during sex
Diseases that can be spread during sex Did you know... over 65 million people in the United States have a chronic, incurable sexually transmitted disease (STD)? and that every year another 19 million persons
More informationZika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases
Zika Virus Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases What is the incubation period for Zika virus infection? Unknown but likely to be several
More informationGUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS
GUIDELINES F THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS World Health Organization WHO Library Cataloguing-in-Publication Data World Health Organization. Guidelines for the management of sexually
More informationSTD Treatment Guidelines
STD Treatment Guidelines Steve Randall, PA The Medical Practice Association of KUSM-W - HIV Program And HIV Educat, The Kansas AIDS Education and Training Center The University of Kansas School of Medicine
More informationAccent on Health Obgyn, PC HERPES Frequently Asked Questions
1. What is herpes? 2. How common is herpes? 3. Is there a cure for herpes? 4. What is oral herpes (cold sores)? 5. How is oral herpes spread? 6. What is genital herpes? 7. How is genital herpes spread?
More informationEmerging Issues in Sexually Transmitted Diseases. Webinar. Managing STDs in Correctional Settings: Behind the Walls
Emerging Issues in Sexually Transmitted Diseases Webinar Managing STDs in Correctional Settings: Behind the Walls Please listen to the webinar on your computer using speakers or a headset. We will compile
More informationFrequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013
Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013 On July 16, 2012, the Food and Drug Administration (FDA) approved
More informationMANAGING HERPES. Living and loving with hsv. American Social Health association. by Charles Ebel & Anna Wald, M.D., M.P.H.
MANAGING HERPES Living and loving with hsv by Charles Ebel & Anna Wald, M.D., M.P.H. American Social Health association RESEARCH TRIANGLE PARK, NORTH CAROLINA contents contents Preface xi Acknowledgments
More informationA randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy
A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy Gavin F. Jacobson, MD, a Amy M. Autry, MD, b Russell S. Kirby, PhD, a Elaine
More informationEffective Integration of STI & HIV Prevention Programs
Effective Integration of STI & HIV Prevention Programs Jeanne Marrazzo, MD, MPH University of Washington, Seattle September 27, 2013 Key Points STIs are really common among those at highest risk of HIV
More informationCDC 2015 STD Treatment Guidelines: What s new?
: What s new? Ellen Opie, RN/FNP, MPH Guest Faculty, CaliforniaPreventionTraining Center Staff, San FranciscoCity Clinic (DPH) Disclosure Information Ellen Opie, RN/FNP MPH I have no financial relationships
More informationThe Treatment ofnon-gonococcal Urethritis with Single Dose Oral Azithromycin
The Journal of International Medical Research 1995; 23: 386-393 The Treatment ofnon-gonococcal Urethritis with Single Dose Oral Azithromycin T ERDOGRU\ A AGA9FIDAff, M ONELz,S BADUR z, 0 ANG 2 AND S TELALLOGLU
More informationThe public health approach to STD control
The public health approach to STD control WORLD BANK UNAIDS Technical Update UNAIDS Best Practice Collection At a Glance & There is a strong link between sexually transmitted diseases (STDs) and the sexual
More information4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED
HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS What is human papillomavirus (HPV)? HPV is the most common sexually transmitted infection. There are
More informationThe challenge of herpes
The challenge of herpes Herpes is a common and personally challenging disease Herpes is very common. One out of four adults has genital herpes. When people first hear that they are infected, many become
More informationSEXUALLY TRANSMITTED INFECTIONS (STIs)
SEXUALLY TRANSMITTED INFECTIONS (STIs) The importance of a renewed commitment to STI prevention and control in achieving global sexual and reproductive health STIs: LARGE BURDEN AND SERIOUS CONSEQUENCES
More informationCONTROL OF NEISSERIA GONORRHOEAE INFECTION IN THE UNITED STATES
CONTROL OF NEISSERIA GONORRHOEAE INFECTION IN THE UNITED STATES REPORT OF AN EXTERNAL CONSULTANTS MEETING CONVENED BY THE DIVISION OF STD PREVENTION, NATIONAL CENTER FOR HIV, STD, AND TB PREVENTION, CENTERS
More informationWA Endemic Regions STI/HIV Control Supplement
WA Endemic Regions STI/HIV Control Supplement MAY 2013 Contents INTRODUCTION... 2 HEALTH UNITS CONTACTS... 3 RATES OF CHLAMYDIA, GONORRHOEA AND SYPHILIS NOTIFICATIONS IN THE GOLDFIELDS, KIMBERLEY, MIDWEST
More informationPatient-Delivered Partner Treatment With Azithromycin to Prevent Repeated Chlamydia trachomatis Infection Among Women
Patient-Delivered Partner Treatment With Azithromycin to Prevent Repeated Chlamydia trachomatis Infection Among Women A Randomized, Controlled Trial JULIA A. SCHILLINGER, MD, MSc,* PATRICIA KISSINGER,
More informationGenital ulcers and concomitant complaints in men attending a STI clinic: implications for STI management
Genital ulcers and concomitant complaints in men attending a STI clinic: implications for STI management Nigel O Farrell 1, 2 MD, FRCP Linda Morison 2, MSc Prashini Moodley 3, MB ChB, PhD Keshree Pillay
More informationAntimicrobial Resistance & Infections. Clinical Perspectives
Antimicrobial Resistance & Sexually Transmitted Infections Clinical Perspectives Outline Neisseria gonorrhoeae Global threat of untreatable gonorrhoea Mycoplasma genitalium Rapid loss of treatment options
More informationBalanitis (change on the helmet of the penis) This is a change in the skin on the glans (helmet) of the penis. It is often caused by either:-
INFECTIONS Bacterial Vaginosis Women with Bacterial Vaginosis (BV) often complain of an increase in vaginal discharge that is "smelly" or they feel "unclean" despite regular washing. This is more noticeable
More informationPreface. TTY: (888) 232-6348 or cdcinfo@cdc.gov. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636)
Preface The purpose of this CDC Hepatitis C Counseling and Testing manual is to provide guidance for hepatitis C counseling and testing of individuals born during 1945 1965. The guide was used in draft
More informationWilliam Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016
William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 Advisory Committee on Immunization Practices (ACIP) The recommendations to be discussed are primarily those of the ACIP composed of 15
More informationOptimizing Treatment of Antimicrobial-resistant Neisseria gonorrhoeae. Kakoli Roy,* Susan A. Wang,* and Martin I. Meltzer* Methods
Subscription Information for Optimizing Treatment of Antimicrobial-resistant Neisseria gonorrhoeae Kakoli Roy,* Susan A. Wang,* and Martin I. Meltzer* The increasing prevalence of ciprofloxacin-resistant
More informationSCREENING FOR SEXUALLY TRANSMITTED INFECTIONS
SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS Take history:- History of presenting problem Full sexual history (refer to guideline on sexual history taking) Relevant past medical history, including previous
More informationUrinary Tract Infections
Urinary Tract Infections Overview A urine culture must ALWAYS be interpreted in the context of the urinalysis and patient symptoms. If a patient has no signs of infection on urinalysis, no symptoms of
More informationImmunization Healthcare Branch. Human Papillomavirus Vaccination Program Questions and Answers. Prepared by
Immunization Healthcare Branch Human Papillomavirus Vaccination Program Questions and Answers Prepared by Immunization Healthcare Branch (IHB), Defense Health Agency Last Updated: 02 Jan 14 www.vaccines.mil
More informationSexually Transmitted Infections
Sexually Transmitted Infections Sexually Transmitted Pathogens Bacteria Neisseria gonorrhoeae Chlamydia trachomatis Mycoplasma genitalium Ureaplasma urealyticum Treponema pallidum Gardnerella vaginalis
More informationEXPEDITED PARTNER THERAPY (EPT) IN THE TREATMENT OF CHLAMYDIA
EXPEDITED PARTNER THERAPY (EPT) IN THE TREATMENT OF CHLAMYDIA Jean Ann Davison, DNP, FNP-BC Clinical Assistant Professor at UNC-Chapel Hill & Hannah E. Schrum, MSN, FNP-BC Chlamydia trachomatis Chlamydia
More informationPreventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64
Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64 1. BMI - Documented in patients medical record on an annual basis. Screen for obesity and offer intensive counseling and behavioral
More informationDiagnosis and Management of Gonococcal Infections
Diagnosis and Management of Gonococcal Infections MEJEBI T. MAYOR, MD, JD, Providence Hospital, Washington, District of Columbia MICHELLE A. ROETT, MD, MPH, Georgetown University/Providence Hospital Family
More informationClinical Scenarios CODING AND BILLING 101. Daryn Eikner, Family Planning Council Ann Finn, Ann Finn Consulting
Clinical Scenarios CODING AND BILLING 101 Daryn Eikner, Family Planning Council Ann Finn, Ann Finn Consulting 1 Always remember Follow coding guidelines If you didn t write it down, it didn t happen The
More informationEtiology and treatment of chronic bacterial prostatitis the Croatian experience
Etiology and treatment of chronic bacterial prostatitis the Croatian experience Višnja Škerk University Hospital for Infectious Diseases "Dr. Fran Mihaljevic" Zagreb Croatia Milano, Malpensa, 14 Nov 2008
More informationCoding and Billing for HIV Services in Healthcare Facilities
P a g e 1 Coding and Billing for HIV Services in Healthcare Facilities The Hawai i State Department of Health STD/AIDS Prevention Branch is pleased to provide you information on billing and reimbursement
More informationAPIC Practice Guidance Committee: Implementation Insights Prevention & Control of Pertussis
1275 K Street, NW, Suite 1000 Washington, DC 20005-4006 Phone: 202/789-1890 Fax: 202/789-1899 apicinfo@apic.org www.apic.org APIC Practice Guidance Committee: Implementation Insights Prevention & Control
More informationLaboratory confirmation requires isolation of Bordetella pertussis or detection of B. pertussis nucleic acid, preferably from a nasopharyngeal swab.
Pertussis Epidemiology in New Zealand New Zealand has continued to experience outbreaks of pertussis in recent decades. This is in part due to historically low immunisation rates and in part because immunity
More informationWhat is the economic burden imposed by antimicrobial resistance in Neisseria gonorrhoeae
What is the economic burden imposed by antimicrobial resistance in Neisseria gonorrhoeae John Tapsall MD BS FRCPA, Director, WHO Collaborating Centre for STD and HIV, Department of Microbiology, The Prince
More information2011 STI Annual Report
STI Annual Report Howard Brown Health Center s third Annual STI Report details sexually transmitted infection (STI) and human immunodeficiency virus (HIV) testing and behavioral trends at many of Howard
More informationSexually Transmitted Infections
Introduction and General Considerations Date Reviewed: July, 2010 Section: 5-10 Page 1 of 13 Background Information The incidence of Sexually Transmitted Infections (STIs) in Saskatchewan has been increasing
More informationSuggested Reporting Language for the HIV Laboratory Diagnostic Testing Algorithm
Suggested Reporting Language for the HIV Laboratory Diagnostic Testing Algorithm November 2013 Introduction In March 2010, the Centers for Disease Control and Prevention (CDC) and the Association of Public
More informationTRICHOMONIASIS AMONG ANTE-NATAL ATTENDEES IN A TERTIARY HEALTH FACILITY, ABEOKUTA, NIGERIA
380 TRICHOMONIASIS AMONG ANTE-NATAL ATTENDEES IN A TERTIARY HEALTH FACILITY, ABEOKUTA, NIGERIA Sammy Olufemi Sam-Wobo*, O. K. Ajao*, Monsuru Adebayo Adeleke** and Uwem Friday Ekpo* * Parasitology Unit,
More informationA Review of Genital Chlamydial Infections
Clinical Review Article A Review of Genital Chlamydial Infections Daniel M. Breitkopf, MD Chlamydiae are obligate intracellular parasites containing both DNA and RNA. 1 Three species of the genus Chlamydia
More information